These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 22943266
1. Acclimatizing with acetazolamide. Basnyat B. J Travel Med; 2012; 19(5):281-3. PubMed ID: 22943266 [No Abstract] [Full Text] [Related]
5. Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide. Bärtsch P, Schneider M. BMJ; 2001 Jan 06; 322(7277):48-9. PubMed ID: 11141168 [No Abstract] [Full Text] [Related]
7. Age is no barrier to success at very high altitudes. Stokes S, Kalson NS, Earl M, Whitehead AG, Tyrrell-Marsh I, Frost H, Davies A. Age Ageing; 2010 Mar 06; 39(2):262-5. PubMed ID: 20068217 [No Abstract] [Full Text] [Related]
8. Acetazolamide for the prophylaxis of acute mountain sickness. Imray C. BMJ; 2012 Oct 31; 345():e7077. PubMed ID: 23114063 [No Abstract] [Full Text] [Related]
9. Acetazolamide Use in an Ultra-Runner: A Complicated Treatment Consideration for AMS. Biondich AS, Joslin JD. Wilderness Environ Med; 2016 Mar 31; 27(1):179-80. PubMed ID: 26520404 [No Abstract] [Full Text] [Related]
10. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis. Ritchie ND, Baggott AV, Andrew Todd WT. J Travel Med; 2012 Mar 31; 19(5):298-307. PubMed ID: 22943270 [Abstract] [Full Text] [Related]
11. Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness. Dumont L, Tramer MR, Lysakowski C, Mardirosoff C, Kayser B. High Alt Med Biol; 2003 Mar 31; 4(3):399; author reply 400. PubMed ID: 14561245 [No Abstract] [Full Text] [Related]
17. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. Basnyat B, Gertsch JH, Holck PS, Johnson EW, Luks AM, Donham BP, Fleischman RJ, Gowder DW, Hawksworth JS, Jensen BT, Kleiman RJ, Loveridge AH, Lundeen EB, Newman SL, Noboa JA, Miegs DP, O'Beirne KA, Philpot KB, Schultz MN, Valente MC, Wiebers MR, Swenson ER. High Alt Med Biol; 2006 Mar 15; 7(1):17-27. PubMed ID: 16544963 [Abstract] [Full Text] [Related]
18. Prophylaxis for acute mountain sickness. Zafren K. Ann Emerg Med; 2012 Nov 15; 60(5):671; author reply 672. PubMed ID: 23089097 [No Abstract] [Full Text] [Related]
19. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial). McIntosh SE, Hemphill M, McDevitt MC, Gurung TY, Ghale M, Knott JR, Thapa GB, Basnyat B, Dow J, Weber DC, K Grissom C. Wilderness Environ Med; 2019 Mar 15; 30(1):12-21. PubMed ID: 30630671 [Abstract] [Full Text] [Related]
20. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. van Patot MC, Leadbetter G, Keyes LE, Maakestad KM, Olson S, Hackett PH. High Alt Med Biol; 2008 Mar 15; 9(4):289-93. PubMed ID: 19115912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]